Editas Medicine Banner Image

Editas Medicine has reached its limit for free report views

Work for Editas Medicine? Upgrade Your Profile and unlock all your annual reports.

Editas Medicine

  • Ticker EDIT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Editas Medicine Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomicMore medicines for a broad class of diseases.
Editas Medicine

Most Recent Annual Report

Editas Medicine MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Editas Medicine has reached its limit for free report views.

Older/Archived Annual Reports